Skip to content
value.today

E-scape Bio, Inc.

Total raised
$167 M
3 rounds on record
Latest round
$73 M
Sep 2020
First round on record
Aug 2015
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of E-scape Bio, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2020$73 MNo. 3$50 to $250 million

E-scape Bio, Inc.: Raise no. 3, Sep 2020

Investors in this round

29 investors had bought by the notice of Sep 28, 2020: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$73 M of $73 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anthony Sanders Rimac · Executive Officer
  • Carrolee Sanders Barlow · Executive Officer
  • Julie Anne Smith · Executive Officer, Director
  • Paul Sanders Wren · Executive Officer
  • Asish Sanders Xavier · Director
  • Laura Anne Brass · Director
  • Perry Anne Karsen · Director
  • Peter Anne Moldt · Director
  • Peter Anne Thompson · Director
  • R. Sanders Williams · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Julie Anne Smith, President and CEO. Source: SEC Form D, newest notice filed Sep 28, 2020. Read the notice at the SEC.

equitySEC
Jul 2019$31 MNo. 2$10 to $50 million

E-scape Bio, Inc.: Raise no. 2, Jul 2019

Investors in this round

22 investors had bought by the notice of Jul 29, 2019: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$31 M of $35 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Julie Anne Smith · Executive Officer, Director
  • Asish Anne Xavier · Director
  • Laura Anne Brass · Director
  • Perry Anne Karsen · Director
  • Peter Anne Moldt · Director
  • Peter Anne Thompson · Director
  • R. Sanders Williams · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes common stock issued to certain purchasers of preferred stock in the financing.”

Signed by Julie Anne Smith, President and CEO. Source: SEC Form D, newest notice filed Jul 29, 2019. Read the notice at the SEC.

equitySEC
Aug 2015$63 MNo. 1$50 to $250 million

E-scape Bio, Inc.: Raise no. 1, Aug 2015

Investors in this round

31 investors had bought by the notice of Oct 11, 2018: 31 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$63 M of $63 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Julie Anne Smith · Executive Officer, Director
  • Asish Sanders Xavier · Director
  • Judith Anne Li · Director
  • Markus Anne Goebel · Director
  • Perry Anne Karsen · Director
  • Peter Anne Moldt · Director
  • Peter Anne Thompson · Director
  • R. Sanders Williams · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jill E. Fishbein, Secretary. Source: SEC Form D and 2 amendments, newest notice filed Oct 11, 2018. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • E-scape Bio, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2020).

    SEC Form D · Sep 2020

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Sep 2020

That is all the official record says: E-scape Bio, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of E-scape Bio, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 31 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by E-scape Bio, Inc.
NameRoleNamed in
Anthony Sanders RimacExecutive officerSep 2020
Carrolee Sanders BarlowExecutive officerSep 2020
Julie Anne SmithExecutive officerSep 2020
Paul Sanders WrenExecutive officerSep 2020
Leon ChenExecutive officerJun 2017
Asish Sanders XavierDirectorSep 2020
Julie Anne SmithDirectorSep 2020
Laura Anne BrassDirectorSep 2020
Perry Anne KarsenDirectorSep 2020
Peter Anne MoldtDirectorSep 2020
Peter Anne ThompsonDirectorSep 2020
R. Sanders WilliamsDirectorSep 2020
Asish Anne XavierDirectorJul 2019
Judith Anne LiDirectorOct 2018
Markus Anne GoebelDirectorOct 2018
Asish XavierDirectorJun 2017
Giovanni FerarraDirectorJun 2017
Judith LiDirectorJun 2017
Leon ChenDirectorJun 2017
Peter MoldtDirectorJun 2017
Peter ThompsonDirectorJun 2017
R Sanders WilliamsDirectorJun 2017
Eric ShiozakiDirectorAug 2015
Giovanni FerraraDirectorAug 2015